Bionano Genomics, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets↓-4.0% -$3M
$74M
Current Assets↑+14.9% +$6M
$45M
Cash & Equivalents↓-67.4% -$6M
$3M
Receivables↑+9.4% +$448K
$5M
Inventory↓-41.0% -$5M
$8M
Net PPE↓-22.7% -$4M
$15M
Goodwill
—
Intangibles↓-55.2% -$5M
$4M
Total Liabilities↓-29.4% -$12M
$29M
Current Liabilities↓-38.6% -$14M
$23M
Account Payables↓-19.7% -$1M
$6M
Long-Term Debt
—
Stockholders Equity↑+25.6% +$9M
$44M
Retained Earnings↓-3.8% -$26M
$-720M
Operating Lease ROU Asset↑+78.3% +$1M
$3M
Operating Lease Liability↑+2097.2% +$3M
$3M
Finance Lease ROU Asset↓-6.2% -$204K
$3M
Gross PP&E↓-6.6% -$3M
$43M
Accumulated Depreciation↑+5.0% +$1M
$28M
Inventory WIP↓-71.8% -$2M
$663K
Inventory Finished Goods↓-61.4% -$3M
$2M
Debt Due Y1
—
Debt Due Y2
—
Debt Due Y3
—
Debt Due Y4
—
Debt Due Y5
—
Total Debt Carrying Amount
—
Contract Asset↓-33.3% -$100K
$200K
Contract Liability↓-12.8% -$179K
$1M
Contract Liability (Current)↓-14.3% -$161K
$967K
Contract Liability (Noncurrent)↓-6.7% -$18K
$249K
Remaining Performance Obligation↓-14.3% -$200K
$1M